Testing the regulatory framework in South Africa – a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis

BACKGROUND: Bacterial vaginosis (BV) increases HIV risk and adverse reproductive outcomes. Standard-of-care (SOC) for BV are antibiotics; however, cure rates are low. Probiotics for vaginal health may be useful in improving cure and recurrence although the regulatory framework governing probiotics a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Infect Dis
Hlavní autoři: Happel, Anna-Ursula, Singh, Ravesh, Mitchev, Nireshni, Mlisana, Koleka, Jaspan, Heather B., Barnabas, Shaun L., Passmore, Jo-Ann S.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350581/
https://ncbi.nlm.nih.gov/pubmed/32650729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05210-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky